Unraveling Potential Sex‐Specific Effects of Cardiovascular Medications on Longevity Using Mendelian Randomization
Background Establishing the sex‐specific efficacy of cardiovascular medications is pivotal to evidence‐based clinical practice, potentially closing the gender gap in longevity. Trials large enough to establish sex differences are unavailable. This study evaluated sex‐specific effects of commonly pre...
Main Authors: | Man Ki Kwok, C. Mary Schooling |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.030943 |
Similar Items
-
Investigating sex-specific associations of lipid traits with type 2 diabetes, glycemic traits and sex hormones using Mendelian randomization
by: Guoyi Yang, et al.
Published: (2023-01-01) -
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
by: Bohan Fan, et al.
Published: (2024-01-01) -
Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
by: Hao Qin, et al.
Published: (2023-07-01) -
Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study
by: Yinsong Xu, MM, et al.
Published: (2024-04-01) -
Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study
by: Wuqing Huang, et al.
Published: (2021-12-01)